Artificial intelligence in healthcare: global implementation, legal regulation, problems and ethical issues
https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.328
Abstract
Objective: To analyze the legal and ethical aspects of regulating artificial intelligence (AI) in medicine in key jurisdictions (United States, European Union, China, Russia), to identify regulatory gaps, ethical dilemmas and prospects for harmonization of standards.
Material and methods. National and international regulatory documents (GDPR, AI Act, FDA, NMPA), scientific publications, clinical cases and regulatory initiatives (IMDRF, WHO) were reviewed. Methods for comparative legal analysis and systematization of ethical and legal norms were used.
Results. Considerable differences in approaches to AI regulation were identified, including flexibility in the US, the ethical centricity in the EU, centralization in China and an emerging framework in Russia. Key issues were emphasized, such as algorithmic bias, AI transparency, responsibility, and the conflict between innovation and security.
Conclusion. The harmonization of international standards, the introduction of dynamic regulation and the strengthening of interdisciplinary cooperation should be pursued to achieve a balance between innovation and the protection of patients' rights.
About the Authors
D. I. Korabelnikov
Moscow Haass Medical and Social Institute
Russian Federation
Russian Federation
5 2nd Brestskaya Str., Moscow 123056
A. I. Lamotkin
Moscow Haass Medical and Social Institute; Central Research Institute of Organization and Informatization of Healthcare
Russian Federation
Russian Federation
5 2nd Brestskaya Str., Moscow 123056;
11 Dobrolyubov Str., Moscow 127254
References
1. Behara K., Bhero E., Agee J.T. AI in dermatology: a comprehensive review into skin cancer detection. Peer J Comput Sci. 2024; 10: e2530. https://doi.org/10.7717/peerj-cs.2530.
2. Sangers T.E., Wakkee M., Moolenburgh F.J., et al. Towards successful implementation of artificial intelligence in skin cancer care: a qualitative study exploring the views of dermatologists and general practitioners. Arch Dermatol Res. 2023; 315 (5): 1187–95. https://doi.org/10.1007/s00403-022-02492-3.
3. Lamotkin A.I., Korabelnikov D.I., Olisova O.Yu., Lamotkin I.A. Patient routing algorithm when using the artificial intelligence program “Derma Onko Check” for differential diagnosis of skin neoplasms. Current Problems of Health Care and Medical Statistics. 2025; 5: 139–59 (in Russ.). https://doi.org/10.24412/2312-2935-2025-5-139-159.
4. Korabelnikov D.I., Lamotkin A.I. Patient routing algorithm in differential diagnosis of cutaneous neoplasms with the combined use of Derma Onko Check and Melanoma Check artificial intelligence software tools. Clinical Review for General Practice. 2025; 6 (12): 71–9 (in Russ.). https://doi.org/10.47407/kr2025.6.11.00715.
5. Lamotkin A.I., Korabelnikov D.I., Lamotkin I.A. Patient routing algorithm for differential diagnosis of skin neoplasms using the artificial intelligence program “Melanoma Check”. Medical Bulletin of the Main Military Cinical Hospital named after N.N. Burdenko. 2025; 4: 6–13 (in Russ.). https://doi.org/10.53652/2782-1730-2025-6-4-06-13.
6. Lamotkin A.I., Korabelnikov D.I., Lamotkin I.A. Preliminary differential diagnosis of benign and malignant tumors from epidermal skin tissue using an artificial intelligence program “Derma Onko Check”. Current Problems of Health Care and Medical Statistics. 2025; 2: 223–42 (in Russ.). https://doi.org/10.24412/2312-2935-2025-2-223-242.
7. Lamotkin A.I., Korabelnikov D.I., Lamotkin I.A., et al. Melanoma check the accuracy of the preliminary diagnosis of malignant melanocytic skin tumors using the artificial intelligence program “Melanoma Check”. Medical Bulletin of the Main Military Cinical Hospital named after N.N. Burdenko. 2025; 1: 42–51 (in Russ.). https://doi.org/10.53652/2782-1730-2025-6-1-42-51.
8. De Bedout V., Williams N.M., Muñoz A.M., et al. Skin cancer and dermoscopy training for primary care physicians: a pilot study. Dermatol Pract Concept. 2021; 11 (1): e2021145. https://doi.org/10.5826/dpc.1101a145.
9. Neretin E.Yu., Titov K.S., Zapirov G.M. Primary early diagnosis of skin melanoma after individual training of doctors. Russian Journal of Clinical Dermatology and Venereology. 2023; 22 (1): 99–105 (in Russ.). https://doi.org/10.17116/klinderma20232201199.
10. Chen J.Y., Fernandez K., Fadadu R.P., et al. Skin cancer diagnosis by lesion, physician, and examination type: a systematic review and meta-analysis. JAMA Dermatol. 2025; 161 (2): 135–46. https://doi.org/10.1001/jamadermatol.2024.4382.
11. Omelyanovskiy V.V., Gorkavenko F.V., Ryagina V.A., et al. Basic approaches to assessment of digital health products and services in the Russian Federation. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2025; 18 (4): 473–82 (in Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.349.
12. Babenko A.I., Pushkarev O.V. Methodological basis of the complex estimation of medical-economic efficiency of public health services. Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences. 2014; 34 (2): 89–94 (in Russ.).
13. Krasnova L.S., Arkova E.S., Luchinin E.A., Kholovnya-Voloskova M.A. Methodological recommendations for organizing and conducting clinical and economic analysis of medical devices. Мoscow: Research Institute of Healthcare Organization and Medical Management; 2022: 60 pp. (in Russ.).
Review
For citations:
Korabelnikov D.I., Lamotkin A.I. Artificial intelligence in healthcare: global implementation, legal regulation, problems and ethical issues. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.328
Views:
712
JATS XML
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 